US REGULATORY RECORDS
- FDA API DMF records
- 15
- Active (A)
- 3
- Inactive (I)
- 12
FDA list cutoff:
ACTIVE PHARMACEUTICAL INGREDIENT
Research Amoxicillin API through FDA DMF and China CDE records. Compare reported holders, registration numbers and status definitions, then subscribe to search and export complete available data.
Complete data requires an active subscription. Already subscribed? Sign in to access your data.
The chemical profile identifies the parent compound, CAS 26787-78-0. Records are selected by reported name; an unspecified hydration state does not establish anhydrous material. Explicit trihydrate, sodium salt and combination entries are excluded.
This overview includes 15 FDA API DMF records and 26 CDE API registrations for Amoxicillin (CAS 26787-78-0), selected by reported substance name. FDA and CDE status counts follow each registry’s own definitions.
FDA list cutoff:
CDE export captured:
0 documented company-name correspondences
The registries have different snapshot dates. Record counts do not represent qualified or available suppliers. Amoxicillin records without a stated hydration state do not establish anhydrous material. A lack of documented company-name correspondences does not establish that no companies appear in both registries.
$19.00 per month
$149.00 per year
Billed $149.00 every year
This profile: 15 FDA DMF records, 26 CDE registrations and 0 company-name correspondences.
One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product. This does not include quotations, supplier qualification or live monitoring.
Start an Amoxicillin supplier search with the reported names in each market. No cross-registry company-name correspondences are documented for this profile. Similar names, translations and membership of the same corporate group do not prove an identical legal entity or manufacturing site.
Free previewShowing 0 sample records of 0.
0 company-name correspondences
No exact company-name correspondences are documented for these snapshots.
Other records remain available below and in the registry tables. A missing name correspondence does not imply a missing registration.
Original reported names are preserved. A CDE company field may contain several named parties; their roles are not inferred from name order. Unmatched names are not treated as ineligible suppliers.
US REGULATORY RECORDS
Compare the original Amoxicillin subjects, holder names, submission dates and activity status. These name-selected entries leave hydration state unspecified; consult the holder for the actual material form.
3Active (A)
12Inactive (I)
A = active; I = inactive. DMFs are neither approved nor disapproved by FDA. These entries do not establish supplier qualification, manufacturing-site approval, dossier access or current availability.
Free previewShowing 3 sample records of 15.
Free preview
More records available with a subscription: 12.
CHINA REGULATORY RECORDS
Review Amoxicillin registration numbers, reported companies, product origins and joint-review identifiers. The source names include plain and 重粉 entries without specifying hydration state.
25Approved for marketed formulations (A)
1Joint review not passed (I)
CDE A and I describe joint-review status, not FDA activity status. In this snapshot, A denotes approval for use in marketed formulations and I denotes material that has not passed joint review with a formulation. Reported validity dates and status do not independently establish current supplier qualification.
Free previewShowing 3 sample records of 26.
Free preview
More records available with a subscription: 23.
Amoxicillin is a penicillin compound identified here by CAS 26787-78-0 and ChEBI CHEBI:2676. The formula and structure describe the parent molecule without water of crystallization or a sodium counterion. A registry subject that simply says Amoxicillin does not verify the physical form supplied by a manufacturer.
Parent compound identity; not a CAS assignment verified individually for every registry record.
Use these parent-compound identifiers to compare chemical references. Amoxicillin trihydrate has a separate CAS number and includes three waters of crystallization. Confirm hydration state, assay basis and the applicable specification with the manufacturer before comparing materials.
Average mass reported by ChEBI for the parent compound; not a batch assay or specification.
Use these official Amoxicillin references to check substance identity and interpret the scope of the registration records.
Compare the formula and stereochemical structure for Amoxicillin, CAS 26787-78-0.
Check the separate CAS numbers and molar masses before comparing Amoxicillin materials.
Understand why an active Amoxicillin DMF does not mean FDA approval of a product or supplier.
Check current Amoxicillin entries and their reported company, packaging and joint-review information.
The chemical profile covers Amoxicillin, CAS 26787-78-0, with molecular formula C16H19N3O5S. Its structure represents the parent compound. The registration tables are selected by reported substance names, so they do not confirm that every listed material is anhydrous.
Amoxicillin trihydrate contains three waters of crystallization and has CAS 61336-70-7. The parent compound has CAS 26787-78-0. These chemical forms have different formula masses; do not compare assay values or specifications without checking their stated basis. Explicit trihydrate entries are excluded from this profile.
The sodium salt and clavulanate combinations identify different chemical forms or mixtures. They are outside this parent-compound profile. The inclusion rules keep those entries separate from Amoxicillin records rather than treating every matching word as the same material.
The FDA snapshot contains 15 Type II Amoxicillin records whose subjects do not explicitly name a hydrate, sodium salt or finished dosage form. USP, bulk substance, compacted material and enzyme-route descriptions are retained. Type II alone is insufficient to identify an API because the category also covers other material and drug products.
No. A and I indicate active and inactive DMFs. FDA states that DMFs are neither approved nor disapproved; technical contents are reviewed with applications that reference them. An Amoxicillin DMF number does not establish manufacturing-site qualification, access to a dossier, current supply or suitability for a particular application.
For these Amoxicillin registrations, A and I describe Chinese review status, independently of FDA activity. A identifies material approved for use in marketed formulations; the regulator describes several routes to A status. I identifies material that has not passed technical review or has not been linked to a formulation registration. Check the current official entry when evaluating regulatory support.
The CDE selection includes 阿莫西林, 阿莫西林(重粉) and 阿莫西林重粉. The 重粉 qualifier describes the reported powder grade and is retained exactly. It does not independently identify a sodium salt, combination product or hydration state. Ask the manufacturer for the physical-form specification instead of assigning a different CAS from this qualifier.
Use the registry number to locate the original entry, then ask the company to confirm its legal name, manufacturing site, chemical form, specification and applicable regulatory documentation. A CDE company field can list multiple parties. This page does not infer their roles from order or equate translated names with an FDA holder.
Review free Amoxicillin samples and download their sample CSV files before subscribing. An active personal subscription provides the complete available records for this profile, with search, status filters and CSV exports. It does not provide quotations, supplier qualification or live registry monitoring.
Official references for chemical identity, registration records and status definitions. Open the original source to check current information.
EMBL-EBI
Parent-compound CAS, molecular formula, calculated masses, InChIKey and stereochemical SMILES.
“C16H19N3O5S”
EMBL-EBI
Molecular formula reported in the ChEBI entry CHEBI:2676.
European Directorate for the Quality of Medicines & HealthCare
The general considerations on page 5 distinguish the anhydrous compound from the trihydrate by CAS and molar mass.
“amoxicillin trihydrate (CAS: 61336-70-7)”
European Directorate for the Quality of Medicines & HealthCare
Chemical-form identification in the EDSForm Working Party expert opinion; not a manufacturer specification.
U.S. Food and Drug Administration
The records displayed here use the second-quarter snapshot, with a June 30, 2026 cutoff. The official page may offer a later quarterly list.
“A=active ; I=inactive”
U.S. Food and Drug Administration
FDA activity-status legend; the snapshot date applies to the records shown here.
U.S. Food and Drug Administration
FDA explains how DMFs support applications that reference their technical contents.
“Are neither approved nor disapproved.”
U.S. Food and Drug Administration
FDA statement about DMFs; active status is not product approval.
U.S. Food and Drug Administration
Type II covers drug substances, intermediates, preparation materials and drug products; a subject-level screen is needed to select API records.
“Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation; or Drug Product”
U.S. Food and Drug Administration
FDA definition of Type II; the category is broader than API-only filings.
Center for Drug Evaluation, National Medical Products Administration
The October 5, 2026 snapshot contains the reported names, company fields and registration information used here.
“阿莫西林”
Center for Drug Evaluation, National Medical Products Administration
Original substance name in the CDE snapshot; the name alone does not specify hydration state.
Liaoning Medical Products Administration
Official explanation of the A and I identifiers, including the different routes by which a record can receive A status.
“未通过技术审评或尚未与制剂注册进行关联的标识为“I”。”
Liaoning Medical Products Administration
The regulator explains I as material that has not passed technical review or has not been linked to a formulation registration.
Compare Amoxicillin registry names, statuses and chemical-form boundaries using the free samples. Subscribe to search, filter and export the complete available FDA and CDE records for your sourcing review.
Complete data requires an active subscription. Already subscribed? Sign in to access your data.
Report an Amoxicillin data issue with the page address, registry number and supporting official source. APIRFQ support handles data corrections; contact the relevant company separately about material specifications or supply.
Contact data support